세계 연속 혈당 모니터링 시장은 2024년부터 2031년까지 15%의 CAGR로 2031년까지 314억 1,000만 달러에 달할 것으로 예측됩니다.
본 보고서는 광범위한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 도전 과제 및 기회 분석으로 구성되어 있습니다. 연속 혈당 모니터링(CGM) 시장의 성장은 당뇨병과 같은 만성질환의 부담 증가와 함께 사람들의 라이프스타일 변화, 기존 혈당 모니터링에 비해 CGM이 제공하는 이점, 운동선수와 피트니스 애호가들의 CGM 사용으로 인해 주도되고 있습니다. 그러나 CGM 장비의 높은 비용과 제품 리콜은 이 시장의 성장을 억제하고 있습니다.
또한 CGM 기기의 기술 발전, 맞춤형 치료로의 전환, 건강 인식의 증가, 신흥국에서의 당뇨병 관리 기기의 접근성 향상으로 시장 성장 기회가 창출될 것으로 예상됩니다. 그러나 진단을 받지 못한 채 살아가는 당뇨병 환자의 수와 CGM 기기의 접착력, 신뢰성 및 정확성과 관련된 문제는 세계 연속 혈당 모니터링 시장의 주요 도전 과제입니다.
(참고 : 상위 5개사 SWOT 분석을 제공합니다)
Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics)-Global Forecast to 2031
The global continuous glucose monitoring market is projected to reach $31.41 billion by 2031 at a CAGR of 15% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the continuous glucose monitoring (CGM) market is driven by lifestyle changes among the population coupled with the growing burden of chronic conditions such as diabetes, the benefits offered by CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. However, high costs and product recalls of CGM devices restrain the growth of this market.
Furthermore, technological advancements in CGM devices, a shift toward personalized care and, rising health awareness, and increasing accessibility for diabetes care devices in developing countries are expected to generate market growth opportunities. However, the high number of people living undiagnosed with diabetes patients and problems related to the adhesiveness, reliability, and accuracy of CGM devices are major challenges in the global continuous glucose monitoring market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the continuous glucose monitoring market are DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).
Among all the components studied in this report, in 2024, the sensors segment is expected to account for the largest share of 52.4% of the continuous glucose monitoring market. The sensors segment is further segmented into disposable sensors and implantable sensors. The large market segment is attributed to the high demand for continuous glucose monitoring and frequent purchases of sensors compared to receivers and transmitters. Sensors require more frequent replacement compared to other components. Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.
Among all the age groups studied in this report, in 2024, the adult segment is expected to account for a larger share of the continuous glucose monitoring market. This segment's large market share can be attributed to the high proportion of the geriatric population with diabetes and changing lifestyles leading to diseases such as obesity, depression, anxiety, and cardiovascular diseases.
Among all the end users studied in this report, in 2024, the home care settings segment is expected to account for a larger share of 82.3% of the continuous glucose monitoring market. The large market share of this segment is attributed to factors such as the high prevalence of diabetes worldwide, rising awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries. CGM technologies provide numerous advantages in home care settings. There is a growing shift toward home healthcare due to the lack of healthcare professionals and increasing consumer awareness regarding the monitoring of diabetic conditions through CGM, which supports the large market share of the segment.
An in-depth analysis of the geographical scenario of the global continuous glucose monitoring market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 17.4% during the forecast period. The market growth of this region is attributed to the advancing healthcare infrastructure, growing disposable income, and rising investments by major key market players. Furthermore, economic growth, as well as technological developments support the market growth in Asia-Pacific.
Continuous glucose monitoring Market Assessment-by Component
Continuous glucose monitoring Market Assessment-by Age Group
Continuous glucose monitoring Market Assessment-by End User
Continuous glucose monitoring Market Assessment-by Geography
(Note: SWOT Analysis will be Provided for The Top 5 Players)